Trevi Therapeutics
TRVI
TRVI
32 hedge funds and large institutions have $79.6M invested in Trevi Therapeutics in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
39% more funds holding
Funds holding: 23 → 32 (+9)
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$32M | |
| 2 | +$8.57M | |
| 3 | +$5M | |
| 4 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$4.56M |
| 5 |
ACM
Altium Capital Management
New York
|
+$3.61M |
Top Sellers
| 1 | -$1.41M | |
| 2 | -$52.5K | |
| 3 | -$52K | |
| 4 |
VF
Virtu Financial
New York
|
-$44K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$33K |